OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
9686$0.9455

Xikang Cloud Hospital Holdings Inc

Healthcare Facilities & ServicesVerified

Xikang Cloud Hospital Holdings Inc has a market capitalization of 791.36 million CNY, with a market price of 0.94 CNY per share. The company's capital structure is currently undiluted, as the number of basic and diluted shares outstanding is identical at 841,876,805. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. In terms of profitability, the company's financial performance relative to industry benchmarks is not available in the current dataset. The valuation snapshot does not include key profitability metrics such as ROIC or EBITDA margins, which are typically used to assess performance in the Healthcare Facilities & Services industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. There is no information on the contribution of different business segments or geographic regions to the company's overall revenue. The growth trajectory of Xikang Cloud Hospital Holdings Inc is not quantified in the current dataset. There are no numeric deltas or revenue history provided to assess the company's performance over time. The absence of detailed financial history limits the ability to project future growth or assess the company's market position. The risk assessment indicates a low dilution potential, as the number of basic and diluted shares is the same. However, the lack of detailed financial data and the absence of going-concern language in the source documents raise concerns about the company's financial health and operational sustainability. There are no recent events or filings disclosed in the available data that would provide insight into the company's current operations or strategic direction. The absence of recent transcripts or filings limits the ability to assess the company's management's outlook or any material developments affecting the business.

30-day price · 9686+0.12 (+14.3%)
Low$0.81High$1.03Close$0.96As of17 May, 00:00 UTC
Profile
CompanyXikang Cloud Hospital Holdings Inc
Ticker9686.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Xikang Cloud Hospital Holdings Inc provides cloud-based hospital services and digital healthcare solutions, primarily generating revenue through subscription models and service fees.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a high confidence level of 0.92 based on verified market data.

Xikang Cloud Hospital Holdings Inc has a market capitalization of 791.36 million CNY, with a market price of 0.94 CNY per share. The company's capital structure is currently undiluted, as the number of basic and diluted shares outstanding is identical at 841,876,805. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. In terms of profitability, the company's financial performance relative to industry benchmarks is not available in the current dataset. The valuation snapshot does not include key profitability metrics such as ROIC or EBITDA margins, which are typically used to assess performance in the Healthcare Facilities & Services industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. There is no information on the contribution of different business segments or geographic regions to the company's overall revenue. The growth trajectory of Xikang Cloud Hospital Holdings Inc is not quantified in the current dataset. There are no numeric deltas or revenue history provided to assess the company's performance over time. The absence of detailed financial history limits the ability to project future growth or assess the company's market position. The risk assessment indicates a low dilution potential, as the number of basic and diluted shares is the same. However, the lack of detailed financial data and the absence of going-concern language in the source documents raise concerns about the company's financial health and operational sustainability. There are no recent events or filings disclosed in the available data that would provide insight into the company's current operations or strategic direction. The absence of recent transcripts or filings limits the ability to assess the company's management's outlook or any material developments affecting the business.
Key takeaways
  • The company's capital structure is undiluted, with no difference between basic and diluted shares outstanding.
  • Liquidity risk remains unassessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.
  • Profitability metrics relative to industry benchmarks are not available in the current dataset.
  • The company's revenue concentration and geographic exposure are not disclosed.
  • Growth trajectory and revenue history are not quantified, limiting the ability to assess future performance.
  • No recent events or filings are disclosed, which limits insight into the company's current operations or strategic direction.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$614.3M-$253.6M-$296.5M-$271.4M
FY-3$687.4M-$195.5M-$242.0M-$216.6M
FY-2$537.7M-$109.6M-$154.7M-$125.5M
FY-1$501.5M-$60.4M-$83.1M-$68.9M
FY0$464.1M-$20.7M-$38.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$946.8M-$274.5M$364.7M
FY-3$934.4M-$452.0M$350.7M
FY-2$1.40B$428.1M$676.8M
FY-1$1.26B$363.3M$760.9M
FY0$1.14B$313.4M$545.5M
PeriodOCFCapExFCFSBC
FY-4-$83.4M-$18.4M-$271.4M
FY-3-$73.8M-$7.3M-$216.6M
FY-2-$20.2M-$4.3M-$125.5M
FY-1$21.6M-$13.4M-$68.9M
FY0
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$0.94
Market cap$791.4M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
Metric9686Activity
Op margin5.6% medp25 -4.2% · p75 12.6%
Net margin2.8% medp25 -3.4% · p75 8.8%
Gross margin36.5% medp25 23.7% · p75 65.2%
CapEx / revenue-4.9% medp25 -11.5% · p75 -2.0%
Debt / equity69.3% medp25 7.9% · p75 120.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:51 UTC#b96b5cc2
Market quoteclose CNY 0.95 · shares 0.84B diluted
no public URL
2026-05-10 09:51 UTC#381ca19d
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 05:26 UTCJob: fdb3a4b5